ArticleMolecular biology and evolution2026
EnhancerDB 2.0: a comprehensive cross-species enhancer atlas.
Article in Molecular biology and evolution, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Enhancers are evolutionarily conserved cis-regulatory elements that drive spatiotemporal gene expression programs underlying development, adaptation, and phenotypic diversity. To clarify the function and regulatory network of enhancers and driven by the rapid growth of large-scale omics data, we developed EnhancerDB 2.0 as an updated version of EnhancerDB 1.0 to facilitate comprehensive profiling of enhancer regulatory networks and multi-omics interpretation of gene regulation. EnhancerDB 2.0 has been expanded from a single human species to five species (human, mouse, zebrafish, fruit fly, and yeast), with the total number of enhancer entries reaching 1,605,856. The database also now provides substantially enriched annotations, including transcription factor binding sites, target genes/miRNAs/lncRNAs, SNPs, CRISPR-Cas9 target sites, chromatin accessibility regions, repeat regions, methylation sites, and GWAS entries, with nearly 100 million annotated entries in total. Furthermore, EnhancerDB 2.0 also features an improved search function and a new analysis module capable of generating publication-quality charts. In summary, EnhancerDB 2.0 provides a user-friendly platform for exploring enhancer-mediated regulation and serves as a valuable resource for researchers in biology, medicine, genetics, and related fields.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.